Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
MERCK's VASOTEC (ENALAPRIL) MAKES ACE-INHIBITOR A TWO-PRODUCT MARKET; APPROVED BY FDA AS 1B DRUG FOR TREATMENT OF "HYPERTENSION OF ALL DEGREES OF SEVERITY"
Jan 06 1986
•
By
The Pink Sheet
More from Archive
More from Pink Sheet